Logo image of MDM.PA

MAISONS DU MONDE SA (MDM.PA) Stock Fundamental Analysis

EPA:MDM - Euronext Paris - Matif - FR0013153541 - Common Stock - Currency: EUR

2.3  +0.22 (+10.58%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MDM. MDM was compared to 55 industry peers in the Specialty Retail industry. Both the profitability and financial health of MDM have multiple concerns. MDM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

MDM had negative earnings in the past year.
In the past year MDM had a positive cash flow from operations.
MDM had positive earnings in 4 of the past 5 years.
In the past 5 years MDM always reported a positive cash flow from operatings.
MDM.PA Yearly Net Income VS EBIT VS OCF VS FCFMDM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

MDM has a Return On Assets of -7.52%. This is in the lower half of the industry: MDM underperforms 76.36% of its industry peers.
The Return On Equity of MDM (-23.13%) is worse than 72.73% of its industry peers.
Industry RankSector Rank
ROA -7.52%
ROE -23.13%
ROIC N/A
ROA(3y)-1.72%
ROA(5y)-0.18%
ROE(3y)-5.33%
ROE(5y)-0.77%
ROIC(3y)N/A
ROIC(5y)N/A
MDM.PA Yearly ROA, ROE, ROICMDM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

MDM has a Gross Margin of 65.54%. This is amongst the best in the industry. MDM outperforms 94.55% of its industry peers.
In the last couple of years the Gross Margin of MDM has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for MDM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.25%
MDM.PA Yearly Profit, Operating, Gross MarginsMDM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

MDM does not have a ROIC to compare to the WACC, probably because it is not profitable.
MDM has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for MDM has been reduced compared to 5 years ago.
The debt/assets ratio for MDM is higher compared to a year ago.
MDM.PA Yearly Shares OutstandingMDM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MDM.PA Yearly Total Debt VS Total AssetsMDM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

MDM has an Altman-Z score of 0.84. This is a bad value and indicates that MDM is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.84, MDM is doing worse than 69.09% of the companies in the same industry.
The Debt to FCF ratio of MDM is 4.88, which is a neutral value as it means it would take MDM, 4.88 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.88, MDM is in line with its industry, outperforming 56.36% of the companies in the same industry.
A Debt/Equity ratio of 0.93 indicates that MDM is somewhat dependend on debt financing.
MDM's Debt to Equity ratio of 0.93 is on the low side compared to the rest of the industry. MDM is outperformed by 70.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 4.88
Altman-Z 0.84
ROIC/WACCN/A
WACC3.32%
MDM.PA Yearly LT Debt VS Equity VS FCFMDM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.72 indicates that MDM may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.72, MDM is doing worse than 85.45% of the companies in the same industry.
MDM has a Quick Ratio of 0.72. This is a bad value and indicates that MDM is not financially healthy enough and could expect problems in meeting its short term obligations.
MDM has a worse Quick ratio (0.32) than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.32
MDM.PA Yearly Current Assets VS Current LiabilitesMDM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for MDM have decreased strongly by -1531.94% in the last year.
MDM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.93%.
MDM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.00% yearly.
EPS 1Y (TTM)-1531.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1359.06%
Revenue 1Y (TTM)-10.93%
Revenue growth 3Y-8.7%
Revenue growth 5Y-4%
Sales Q2Q%-12.06%

3.2 Future

The Earnings Per Share is expected to grow by 23.05% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 0.54% on average over the next years.
EPS Next Y6.31%
EPS Next 2Y35.9%
EPS Next 3Y27.67%
EPS Next 5Y23.05%
Revenue Next Year-6.4%
Revenue Next 2Y-2.22%
Revenue Next 3Y-1.52%
Revenue Next 5Y0.54%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MDM.PA Yearly Revenue VS EstimatesMDM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
MDM.PA Yearly EPS VS EstimatesMDM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1 1.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

MDM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MDM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDM.PA Price Earnings VS Forward Price EarningsMDM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MDM indicates a rather cheap valuation: MDM is cheaper than 92.73% of the companies listed in the same industry.
MDM's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MDM is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.63
EV/EBITDA 3.24
MDM.PA Per share dataMDM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

A more expensive valuation may be justified as MDM's earnings are expected to grow with 27.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.9%
EPS Next 3Y27.67%

More info and screens

0

5. Dividend

5.1 Amount

MDM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAISONS DU MONDE SA

EPA:MDM (8/11/2025, 7:00:00 PM)

2.3

+0.22 (+10.58%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)07-25 2025-07-25
Earnings (Next)10-23 2025-10-23
Inst Owners49.09%
Inst Owner ChangeN/A
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap90.14M
Analysts50
Price Target2.53 (10%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.06
Dividend Growth(5Y)-33.7%
DP-2.01%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-26.96%
PT rev (3m)-35.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.03%
Revenue NY rev (3m)-1.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF 0.63
P/OCF 0.54
P/B 0.18
P/tB 20.85
EV/EBITDA 3.24
EPS(TTM)-3
EYN/A
EPS(NY)-0.53
Fwd EYN/A
FCF(TTM)3.64
FCFY158.31%
OCF(TTM)4.23
OCFY183.81%
SpS26.29
BVpS12.73
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.52%
ROE -23.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.54%
FCFM 13.85%
ROA(3y)-1.72%
ROA(5y)-0.18%
ROE(3y)-5.33%
ROE(5y)-0.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.25%
F-Score5
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 4.88
Debt/EBITDA 2.25
Cap/Depr 10.12%
Cap/Sales 2.23%
Interest Coverage N/A
Cash Conversion 80.16%
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.32
Altman-Z 0.84
F-Score5
WACC3.32%
ROIC/WACCN/A
Cap/Depr(3y)24.05%
Cap/Depr(5y)25.74%
Cap/Sales(3y)3.48%
Cap/Sales(5y)3.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1531.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1359.06%
EPS Next Y6.31%
EPS Next 2Y35.9%
EPS Next 3Y27.67%
EPS Next 5Y23.05%
Revenue 1Y (TTM)-10.93%
Revenue growth 3Y-8.7%
Revenue growth 5Y-4%
Sales Q2Q%-12.06%
Revenue Next Year-6.4%
Revenue Next 2Y-2.22%
Revenue Next 3Y-1.52%
Revenue Next 5Y0.54%
EBIT growth 1Y-152.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6424.15%
EBIT Next 3Y331.79%
EBIT Next 5Y200.53%
FCF growth 1Y-7.74%
FCF growth 3Y-11.59%
FCF growth 5Y-6.1%
OCF growth 1Y-12.21%
OCF growth 3Y-13.81%
OCF growth 5Y-8.3%